Sensei Biotherapeutics (SNSE) News and press releases

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

18 May 22

Pre-Market Outlook, Markets, Movers

Stocks That Hit 52-Week Lows On Monday

16 May 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Monday, 198 companies reached new 52-week lows.

Recap: Sensei Biotherapeutics Q1 Earnings

10 May 22

Earnings, News

Sensei Biotherapeutics (NASDAQ:SNSE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Sensei Biotherapeutics Q1 EPS $(0.40) Up From $(0.42) YoY

10 May 22

Earnings, News

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(0.40) per share. This is a 4.76 percent increase over losses of $(0.42) per share from the same period last year.

Stocks That Hit 52-Week Lows On Friday

29 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Friday, 213 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

28 Apr 22

News, Options, Intraday Update, Markets

During Thursday, 849 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

26 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Stocks That Hit 52-Week Lows On Friday

22 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Friday, 431 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

18 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Monday, 466 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

4 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Monday, 78 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

25 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Friday, 166 companies set new 52-week lows.

12 Health Care Stocks Moving In Wednesday's After-Market Session

23 Mar 22

Movers

Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the press release, Q4 earnings came out 2 days ago.

Stocks That Hit 52-Week Lows On Wednesday

16 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Wednesday, 90 companies set new 52-week lows.

12 Health Care Stocks Moving In Tuesday's After-Market Session

15 Mar 22

Movers

Gainers

Stocks That Hit 52-Week Lows On Friday

11 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

During Friday's session, 198 companies made new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

10 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

During Thursday, 166 stocks hit new 52-week lows.

Piper Sandler Maintains Overweight on Sensei Biotherapeutics, Lowers Price Target to $10

10 Mar 22

News, Price Target, Analyst Ratings

Piper Sandler analyst Joseph Catanzaro maintains Sensei Biotherapeutics (NASDAQ:SNSE) with a Overweight and lowers the price target from $12 to $10.

Stocks That Hit 52-Week Lows On Tuesday

8 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

Tuesday's session saw 729 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Monday

7 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Monday, 524 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Wednesday

2 Mar 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

Wednesday's session saw 107 companies set new 52-week lows.

Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights

10 May 22

Earnings, Press Releases

- SNS-101 preclinical data provide encouraging validation of pH-sensitive approach to inhibiting VISTA with high selectivity to treat solid tumors - - Cash runway extended into the first quarter of 2025 with $136.2

Sensei Biotherapeutics Reports Full Year 2021 Financial Results and Business Highlights

10 Mar 22

Earnings, Press Releases

- Reported preclinical proof of concept data from TMAb platform demonstrating potent and selective pH-dependent binding to "active" VISTA - - Initiated 2 new therapeutic programs and IND-enabling studies with

Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors

9 Mar 22

News, Health Care, Management, Press Releases

BOSTON, March 09, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immunotherapy company focused on the discovery and development of next-generation therapeutics for cancer, today announced the

Sensei Biotherapeutics to Participate in the 32nd Annual Oppenheimer Healthcare Conference

3 Mar 22

News, Health Care, Management, Press Releases

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that